Cyclophosphamide versus placebo in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.The New England journal of medicine. 2006, Vol 354, Num 25, pp 2655-2666, issn 0028-4793, 12 p.Article

Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT TrialHUNG, Emily W; MAYES, Maureen D; MINEISHI, Shin et al.Journal of rheumatology. 2013, Vol 40, Num 4, pp 455-460, issn 0315-162X, 6 p.Article

MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon : A Randomized, Controlled TrialCHUNG, Lorinda; SHAPIRO, Lee; SMITH, Edwin et al.Arthritis and rheumatism. 2009, Vol 60, Num 3, pp 870-877, issn 0004-3591, 8 p.Article

Recombinant Human Relaxin in the Treatment of Systemic Sclerosis With Diffuse Cutaneous Involvement : A Randomized, Double-Blind, Placebo-Controlled TrialKHANNA, Dinesh; CLEMENTS, Philip J; STEEN, Virginia D et al.Arthritis and rheumatism. 2009, Vol 60, Num 4, pp 1102-1111, issn 0004-3591, 10 p.Article

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.American journal of respiratory and critical care medicine. 2007, Vol 176, Num 10, pp 1026-1034, issn 1073-449X, 9 p.Article

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease : Results from the scleroderma lung studyKHANNA, Dinesh; XIAOHONG YAN; RILEY, David J et al.Arthritis and rheumatism. 2007, Vol 56, Num 5, pp 1676-1684, issn 0004-3591, 9 p.Article

The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: A meta-regressionAMIN, Shreyasee; LAVALLEY, Michael P; SIMMS, Robert W et al.Journal of bone and mineral research (Print). 2002, Vol 17, Num 8, pp 1512-1526, issn 0884-0431Article

B Cell Depletion With Rituximab in Patients With Diffuse Cutaneous Systemic SclerosisLAFYATIS, Robert; KISSIN, Eugene; YORK, Michael et al.Arthritis and rheumatism. 2009, Vol 60, Num 2, pp 578-583, issn 0004-3591, 6 p.Article

Durometry for the assessment of skin disease in systemic sclerosisKISSIN, Eugene Y; SCHILLER, Aileen M; GELBARD, Rondi B et al.Arthritis care and research. 2006, Vol 55, Num 4, pp 603-609, issn 0893-7524, 7 p.Article

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Type I Collagen Treatment in Patients With Diffuse Cutaneous Systemic Sclerosis I. Oral Type I Collagen Does Not Improve Skin in All Patients, but May Improve Skin in Late-Phase DiseasePOSTLETHWAITE, Arnold E; WENG KEEWONG; MORELAND, Larry et al.Arthritis and rheumatism. 2008, Vol 58, Num 6, pp 1810-1822, issn 0004-3591, 13 p.Article

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonMERKEL, Peter A; HERLYN, Karen; ROTHFIELD, Naomi F et al.Arthritis and rheumatism. 2002, Vol 46, Num 9, pp 2410-2420, issn 0004-3591, 11 p.Article

Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival AnalysisSHARIF, Roozbeh; FRITZLER, Marvin J; MOLITOR, Jerry A et al.Journal of rheumatology. 2011, Vol 38, Num 8, pp 1622-1630, issn 0315-162X, 9 p.Article